Merck
MRK
#44
Rank
A$491.73 B
Marketcap
A$199.47
Share price
-3.61%
Change (1 day)
36.20%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$1.48

According to Merck's latest financial reports the company's current EPS (TTM) is A$1.49. In 2025 the company made an earnings per share (EPS) of A$10.98 an increase over its 2024 EPS that were of A$10.15.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.48-86.51%
2025A$10.988.15%
2024A$10.154308.46%
2023A$0.23-97.32%
2022A$8.6110.92%
2021A$7.7684.68%
2020A$4.20-27.2%
2019A$5.7763.44%
2018A$3.53151.11%
2017A$1.41-54.58%
2016A$3.1030.21%
2015A$2.38-61.99%
2014A$6.25180.51%
2013A$2.23-31.82%
2012A$3.276.62%
2011A$3.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.03 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.88 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.06 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.39 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.10 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.97 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.79 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.68-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel